BioSpace News Archive

Biotech Beach

Mirati Therapeutics To Present At Jefferies 2019 Global Healthcare Conference

Charles M. Baum, M.D., Ph.D., President and Chief Executive Officer will present a corporate overview at the conference.

May 30, 2019
·
2 min read
Policy

FDA puts company on notice for marketing unapproved stem cell products for treating serious conditions

Arizona company claims their products can treat Lyme disease, diabetes, Parkinson’s disease and more, but have not been approved for any use

May 30, 2019
·
5 min read
Genetown

Waters Novel Cyclic IMS and New SYNAPT XS Lead Full Portfolio of Mass Spectrometry Innovations at ASMS

First-of-its-Kind Cyclic IMS Provides Unlimited Experimental Opportunities while the Research-Grade SYNAPT XS Brings Analytical Flexibility

May 30, 2019
·
6 min read
Pharm Country

The Greater Philadelphia Region’s Place at the Forefront of Cell and Gene Therapy and Connected Health Research and Treatment To Be Showcased During BIO 2019 in Philadelphia

Tri-State Effort Touts Life Sciences Assets to Attract More Companies, Talent and Investment

May 30, 2019
·
8 min read
Biotech Beach

Published Study Demonstrates Feasibility of a Blood Test to Predict Disease Progression and Metastasis in Localized Prostate Cancer

The study, conducted in collaboration with the University of Michigan utilizing Epic’s CTC technology platform, is published here in the Journal of Clinical Oncology Precision Oncology.

May 30, 2019
·
3 min read
Drug Development

Tolero Pharmaceuticals Advances Investigational Agent TP-0903 into Phase 1b Expansion Stage of Study in Patients with Advanced Solid Tumors

The maximum tolerated dose (MTD) of TP-0903 was established during the Phase 1a portion of the study, allowing the study to advance to the Phase 1b stage.

May 30, 2019
·
4 min read
Deals

Argon Medical Devices Acquires Mana-Tech, Ltd.

The acquisition of Mana-Tech, Ltd. represents a compelling growth opportunity to expand commercial reach in the UK, Ireland and throughout Europe

May 30, 2019
·
1 min read
Business

Lantheus Announces Strategic Collaboration with NanoMab to Provide a Novel Biomarker for Clinical Development and Management of Immuno-Oncology Therapies

Lantheus expands into immuno-oncology and pharmaceutical services business through the license of NanoMab’s NM-01, an anti-PD-L1 imaging biomarker, designed to evaluate tumor immune activity and potentially guide future patient selection for immuno-oncology treatment

May 30, 2019
·
5 min read
Pharm Country

Schrödinger to Present at the Jefferies 2019 Global Healthcare Conference

Schrödinger today announced that Ramy Farid, Ph.D., chief executive officer, will present at the Jefferies 2019 Global Healthcare Conference on Thursday, June 6, 2019 at 11:00 a.m. ET in New York, NY.

May 30, 2019
·
1 min read
Bio NC

Rensselaer Polytechnic Realizes Multiple Benefits with JAGGAER’s Chemical Inventory Management Technology

Rensselaer Polytechnic Institute (RPI), America’s first technological research university, has found increased efficiencies in multiple critical areas after performing a complete digital transformation utilizing JAGGAER’s advanced Enterprise Reagent Manager (ERM).

May 30, 2019
·
5 min read